0001104659-20-128060.txt : 20201120
0001104659-20-128060.hdr.sgml : 20201120
20201120173615
ACCESSION NUMBER: 0001104659-20-128060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201120
FILED AS OF DATE: 20201120
DATE AS OF CHANGE: 20201120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patient Square Capital LLC
CENTRAL INDEX KEY: 0001827614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39597
FILM NUMBER: 201333607
BUSINESS ADDRESS:
STREET 1: 8240 MCDANIEL ROAD
CITY: FORT WORTH
STATE: TX
ZIP: 76126
BUSINESS PHONE: 212-446-4600
MAIL ADDRESS:
STREET 1: 8240 MCDANIEL ROAD
CITY: FORT WORTH
STATE: TX
ZIP: 76126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Montes Archimedes Acquisition Corp
CENTRAL INDEX KEY: 0001819263
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 724 OAK GROVE, SUITE 130
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 212-446-4600
MAIL ADDRESS:
STREET 1: 724 OAK GROVE, SUITE 130
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
a4.xml
4
X0306
4
2020-11-20
0
0001819263
Montes Archimedes Acquisition Corp
MAAC
0001827614
Patient Square Capital LLC
724 OAK GROVE, SUITE 130
MENLO PARK
CA
94025
0
0
1
0
Class B common stock
2020-11-20
4
J
0
1232044
D
Class A common stock
1232044
10167956
D
This Form 4 reflects the automatic surrender to the issuer of 1,285,637 of the issuer's shares of Class B common stock, par value $0.0001 per share, for no consideration by the reporting person pursuant to contractual arrangements with the issuer, triggered by the expiration of the option of the underwriter of the issuer's initial public offering to purchase additional units.
As described in the issuer's registration statement on Form S-1 (File No. 333-248802) under the heading "Description of Securities-Founder Shares", the shares of Class B common stock, par value $0.0001, will automatically convert into shares of Class A common stock, par value $0.0001, of the issuer at the time of the issuer's initial partnering transaction on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
This Form 3 is being filed by Patient Square Capital LLC, sponsor of the issuer ("Sponsor"). Sponsor is controlled by James C. Momtazee.
Patient Square Capital LLC, By: /s/ James C. Momtazee, Chief Executive Officer
2020-11-20